Loading...
Back to narrative

TCAP: Higher Discount Rate Should Still Support Attractive Upside Potential

Update shared on 14 Dec 2025

Fair value Decreased 4.81%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-2.1%
7D
1.0%

Analysts have nudged their price target on TP ICAP Group slightly lower, trimming fair value from approximately £3.28 to £3.12. They have incorporated a modestly higher discount rate and slightly softer long term revenue growth assumptions, partly offset by improved profit margin expectations and a lower future P/E multiple.

Valuation Changes

  • Fair Value Estimate reduced slightly from £3.28 to approximately £3.12 per share.
  • Discount Rate risen modestly from 12.94 percent to 13.19 percent, reflecting a slightly higher risk or return requirement.
  • Revenue Growth trimmed marginally from about 3.48 percent to 3.37 percent per year in the long term.
  • Net Profit Margin improved slightly from roughly 8.66 percent to 8.88 percent, indicating a more optimistic profitability outlook.
  • Future P/E Multiple lowered from about 15.15x to 13.95x, implying a more conservative valuation framework.

Have other thoughts on TP ICAP Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.